EUSA Pharma, a transatlantic speciality pharmaceutical company, has acquired US-based oncology and pain control specialist Cytogen for an estimated $50m.(Business Digest)(Brief article)
EUSA Pharma, a transatlantic speciality pharmaceutical company, has acquired US-based oncology and pain control specialist Cytogen …
Комментариев нет:
Отправить комментарий